Formulation | TBS,1%BSA,0.02%azide,pH7.4 |
Storage | 4°C |
Purity | >95%bySDS-PAGE |
ActivityDetermination | N/A |
ShelfLife(properlystored) | 12months |
Gel | Novex4-12%Bis-Tris |
---|---|
Load | BovineLactadherin,1µgperlane |
Buffer | MOPS |
Standard | SeeBluePlus2;Myosin(191kDa),PhosphorylaseB(97kDa),BSA(64kDa),GlutamicDehydrogenase(51kDa),AlcoholDehydrogenase(39kDa),CarbonicAnhydrase(28kDa),MyoglobinRed(19kDa),Lysozyme(14kDa) |
Lactadherinisawidelydistributedglycoprotein(~50kDa),whichwasoriginallycharacterizedduetoitsassociationwithmilkfat/lipidglobulemembranes.SynonymousnamesarePAS-6/7,bovine-associatedmucoprotein,BA-46,P47,andMFG-E8.Structuralhallmarksoflactadherinarethepresenceoftwoepidermalgrowthfactor(EGF)homologydomains(withanRGDpeptidemotifinthesecondEGFdomain),andtwoCdomainssharinghomologywiththediscoidinfamilyoflectindomainsincludingthephospholipid-bindingdomainsofbloodclottingfactorsVandVIII.Lactadherinshowspreferentialbindingtophosphatidylserine(L-form)inacalciumindependentmanner,andbindsmorespecificallythanAnnexinV.
Purifiedlactadherinfunctionsasananticoagulantbyblockingphosphatidylserine-containingmembranesitesforbloodcoagulationproteins(10).Fluoresence-labeledlactadherinfunctionsasasensitiveprobeforexposedphosphatidylserineonnucleatedcellsandonstimulatedplatelets(8,9).LactadherinwillbindtomembranesthathavephosphatidylserinecontentbelowthethresholdforannexinVbinding.
Lactadherinispurifiedfromun-pasteurizedbovinemilk(11).
IllustratedApplications
Above:K562cells(top)andHL60cells(bottom)co-stainedwithbothFITC-conjugatedlactadherin(green)andAlexa-647conjugatedannexinV(red)earlyinapoptosis.Theannexinisinternalizedingranulesandisnotdetectablystainingthecells. Reference:Shi,J.,Y.Shi,L.N.Waehrens,J.T.Rasmussen,C.W.HeegaardandG.E.Gilbert(2006)."Lactadherindetectsearlyphosphatidylserineexposureonimmortalizedleukemiacellsundergoingprogrammedcelldeath."CytometryA69(12):1193-201. Copyright2006. JohnWiley&Sons,Inc. ReprintedwithpermissionofJohnWiley&Sons,Inc.
Above:HeLacellsstainedwithFITC-conjugatedlactadherin2hours(top)and3hours(bottom)aftertreatmentwithstaurosporine.Earlyinapoptosisthecellshavesmallvesiclesandlong,thinappendagesthatstainavidlyforlactadherin.Reference:WaehrensLN,Heeghaard,CW,GilbertGE,RasmussenJT.BovineLactadherinasaCalcium-independentImagingAgentofPhosphatidylserineExpressedontheSurfaceofApoptoticHeLaCells2009J.Histochem.Cytochem.(ePubJune2009).
Above:Phosphatidylserineexposureinmousemesentericvenousthrombosis. Miceweregiven1µgeachoflactadherinandannexinVbytailveinimmediatelypriortoexternalizationofthemesentery.Themesentarywasexposedtoferricchlorideandthentheanimalswereperfusedwithsaline/paraformaldehyde.Serialsectionsofthemesentarywerestainedwithanti-fibrinogen/fibrin(left),anti-platelet(middle),andanti-lactadherinantibodies(right)developedwiththealkalinephosphataseVectorRedsubstrate.Alayeroffibrinogen/fibrin(left,closedarrows)overlaidamuralhemorrhage(openstar).Platelets(middle)werescatteredalongtheluminalsurfaceofthethrombus(opentriangles)aswellasuponfibrinogen/fibrinstrandsextendingintothelumen.Lactadherinstaining(right)wasstrongestalongtheraisedendotheliumsurface(closedarrow),includingadherentplateletsclosetothewall.Plateletsonfibrinstrandsdidnotstaindetectably(openarrow).(ShiJ,PipeSW,RasmussenJT,HeegaardCW,GilbertGE.Lactadherinblocksthrombosisandhemostasisinvivo:correlationwithplateletphosphatidylserineexposure.JThrombHaemost.Jul2008;6(7):1167-1174).
Names | Lactadherin,MFG-E8,PAS-6/7,SED1,p47 | |||||
---|---|---|---|---|---|---|
Localization | Milk(1),alsosecretedbystimulatedmacrophages(2),vascularsmoothmuscle(3),endothelialcells(4) | |||||
Plasmaconcentration | unknowninnormaladults,measurableinwomenwithmetastaticbreastcancer(5),measurableinnewborncalvesaftermilkmeal(1) | |||||
Modeofaction | Physiologicfunctionasopsoninorbridgeligand(6,7).Thelectin-likedomainsengagephosphatidyl-L-serine,thesecondEGFdomainengagesavb3and/oravb5integrinleADIngtophagocytosisofapoptoticcells. | |||||
Molecularweight | 52kDaand47kDa(glycosylationvariants,PAS-6andPAS-7respectively) | |||||
Extinctioncoefficient |
| |||||
Structure | singlechainwithtwoEGFdomainsandtwoCdomains.ThemouseisoformcontainsacentralprolinerichregionandthehumanmoleculecontainsasingleEGFdomain | |||||
Percentcarbohydrate | 6%,13%forglycosylationvariants | |||||
Post-translationalmodifications | glycosylation |
Haemtech生物制药服务(HBS)是一家领先的,符合cGMP要求的QC测试实验室,专门为生产重组和血浆衍生蛋白疗法的生物制药制造商提供分析服务,重点是那些会影响止血系统的药物。HBS使客户能够满足法规和质量测试要求,从而将其候选药物从开发转向商业化。
对生物制药的需求正在增长,并且该行业正在迅速采用外包策略,以作为满足不断升级的监管要求的一种方式。凭借在止血方面的丰富经验,HBS能够很好地协助开发影响凝血系统的药物产品。